Today: 13 June 2026
Why Samsara (IOT) stock is on watch: Canada expansion and March 5 earnings date
3 February 2026
1 min read

Why Samsara (IOT) stock is on watch: Canada expansion and March 5 earnings date

New York, Feb 3, 2026, 08:47 EST — Premarket

  • Shares dipped roughly 0.3% in premarket action, following a sharp 5.8% drop the day before.
  • Samsara revealed plans to expand further into Canada, highlighting local data hosting and new partnerships.
  • The company scheduled its quarterly and full-year results for March 5.

Samsara shares dipped roughly 0.3% to $26.33 in Tuesday’s premarket. On Monday, the stock closed down 5.8% at $26.41.

The drop hinges on two updates from the company that came out just a day apart: a broader push into Canada and a confirmed date for the upcoming earnings release. Each alone might fly under the radar, but side by side, they shape the story for now.

The Canada push targets customers focused on data location and fast hardware delivery. This is crucial for fleets and public agencies bound by strict regulations and lengthy procurement processes. The move unfolds as investors eye the next outlook.

The company announced plans to grow its Canadian presence by ensuring data residency—storing and processing data within Canada—and setting up local fulfillment for hardware. Liz Klein highlighted that their progress in Canada stems from tackling “the specific, complex challenges our customers face.” She emphasized the goal of letting customers sidestep having to “choos[e] between regulatory compliance and cutting-edge innovation.” Samsara

The company highlighted a dedicated Canada data centre on Amazon Web Services and noted partnerships with Ottawa Logistics and Element Fleet Management. It also mentioned a deployment by First Student and quoted Marco Goodridge of Sterling Crane Canada, who described the switch as “a game changer.” Samsara

Separately, Samsara announced it will report fourth-quarter and full-year results for the period ending Jan. 31 after U.S. markets close on March 5, with a webcast to follow.

Traders are zeroing in on that date as the next major catalyst. It marks the company’s fiscal year-end, a period when shifts in sales and spending often impact results and guidance.

Samsara offers software and connected devices to track vehicles and equipment, including safety cameras and telematics—tools that monitor asset locations and usage. The Canada package focuses heavily on compliance and logistics, rather than just adding new features.

The company remains in a crowded field. Fleet and asset-tracking platforms battle over data quality, uptime, and regulatory compliance. Customers consider price, hardware deployment, and how seamlessly these tools fit into their current workflows.

The downside is clear: growth requires cash, and returns might take time. If March guidance points to weaker demand, slower bookings, or increased spending on data centres and fulfilment, the stock could remain under pressure.

Investors are eyeing March 5 for fresh insights on growth and margins, along with subscription metrics like annual recurring revenue (ARR), which tracks run-rate subscription sales, and net new annual contract value, a key indicator of new bookings.

Stock Market Today

  • Rezolve AI Plans $300 Million Buyback Amid Valuation Debate
    June 12, 2026, 6:08 PM EDT. Rezolve AI (RZLV) is under the spotlight after announcing a US$300 million share buyback funded from cash reserves. Trading at US$2.53, the stock gained 5.86% in one day but shows a 9.96% decline over 30 days. The company reaffirmed its 2026 revenue guidance and appointed a new Chief Marketing Officer, signaling confidence in growth. A popular market narrative values the stock at US$10.00, suggesting significant undervaluation, driven by potential recurring revenue growth and improved margins. However, risks around ambitious revenue targets and vendor integrations persist. Contrarily, some models, like Simply Wall St's discounted cash flow analysis, value the stock as low as US$0.15. Investors face a wide valuation gap, weighing Rezolve AI's future growth prospects against execution risks.

Latest articles

Alumis Shares Surge 16% as Traders Eye New Drug Move

Alumis Shares Surge 16% as Traders Eye New Drug Move

12 June 2026
Alumis soared 15.55% to $24.15 on double average volume after strong analyst support and late-stage psoriasis data, but remains a high-risk, loss-making biotech with no approved products; key investor focus is on Phase 2b lupus data due Q3 and a planned psoriasis NDA filing in Q4, with future stock moves hinging on these clinical and regulatory milestones.
Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares
Previous Story

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Microsoft stock price slips early: MSFT hit by Azure glitches as OpenAI spreads across clouds
Next Story

Microsoft stock price slips early: MSFT hit by Azure glitches as OpenAI spreads across clouds

Go toTop